Mycophenolate Dose Reduction in Tacrolimus-based Regimens and Long-term Kidney Transplant Outcomes in Australia and New Zealand.
Darren LeeKevan R PolkinghorneHelen PilmoreWilliam R MulleyPublished in: Transplantation direct (2024)
Early MDR was a risk factor for subsequent rejection and graft failure in KTRs receiving contemporary tacrolimus-based regimens.